RAC 4.81% $3.27 race oncology ltd

I am speaking here in my personal capacity (Daniel Tillett), but...

  1. 1,544 Posts.
    lightbulb Created with Sketch. 4624
    I am speaking here in my personal capacity (Daniel Tillett), but I since I came to RAC we have done things differently. I cornerstoned the raise back in August 2019 and insisted that it be done at a premium to change market sentiment. I am firmly of the opinion that if you look after your shareholders they will return the favour. I think the success of RAC over the last 18 months or so is a perfect example of this principle paying off for all shareholders.

    I am not a great believer in the conventional way listed biotech companies in Australia manage their capital needs. Biotech is an expensive undertaking, but far too many biotechs here take a "management-first" approach of raising a large amount of cash at a steep discount which they then sit on 3 or 4 years. While this makes life easy for management, it does the average investors no good to see their holding diluted down to almost nothing by excessive capital raises.

    I am sure while I am at RAC we will continue to approach all the things we do in innovative ways.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Mkt cap ! $461.3M
Open High Low Value Volume
$3.14 $3.40 $3.14 $1.233M 376.3K

Buyers (Bids)

No. Vol. Price($)
1 989 $3.27

Sellers (Offers)

Price($) Vol. No.
$3.29 1371 1
View Market Depth
Last trade - 16.10pm 07/05/2021 (20 minute delay) ?
0.150 ( 2.52 %)
Open High Low Volume
$3.25 $3.34 $3.25 8912
Last updated 15.55pm 07/05/2021 (live) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.